Final Answer:
True. When signing the FDA Form 1572, the investigator confirms that he/she has read the investigator's brochure.
Step-by-step explanation:
The FDA Form 1572, also known as the Statement of Investigator, is a document used in clinical trials. When an investigator signs this form, they are confirming their commitment to conducting the trial in compliance with regulatory requirements. This includes confirming that they have read the investigator's brochure, which provides essential information about the investigational product, including its properties, risks, and potential benefits. By signing the FDA Form 1572, the investigator acknowledges their understanding of the study drug and their responsibility to conduct the trial according to the protocol, Good Clinical Practice (GCP), and applicable regulatory guidelines.
Option True is the answer.